Sun Pharmaceutical Industries is currently trading at Rs. 448.75, up by 12.00 points or 2.75% from its previous closing of Rs. 436.75 on the BSE.
The scrip opened at Rs. 451.50 and has touched a high and low of Rs. 454.40 and Rs. 445.85 respectively. So far 496017 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 678.80 on 06-Sep-2018 and a 52 week low of Rs. 375.40 on 18-Jan-2019.
Last one week high and low of the scrip stood at Rs. 454.40 and Rs. 421.00 respectively. The current market cap of the company is Rs. 104790.95 crore.
The promoters holding in the company stood at 54.38%, while Institutions and Non-Institutions held 32.53% and 13.09% respectively.
Sun Pharmaceutical Industries has reported a net loss of Rs 38.68 crore for the quarter ended December 31, 2018 against net profit of Rs 320.65 crore for the same quarter in the previous year. Total income of the company decreased by 6.26% at Rs 2289.02 crore for Q3FY19 as compared Rs 2441.90 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported around 4-fold jump in its net profit at Rs 1,241.85 crore for the quarter ended December 31, 2018 as compared to Rs 321.57 crore for the same quarter in the previous year. Total income of the company increased by 16.97% at Rs 7,933.25 crore for Q3FY19 as compared Rs 6,782.42 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1786.05 |
Dr. Reddys Lab | 1354.20 |
Cipla | 1470.05 |
Lupin | 2190.50 |
Zydus Lifesciences | 1004.05 |
View more.. |